10 projects to receive funding through OICR-CCO Health Services Research Network

/0 Comments/in /by
New research projects to drive clinical adoption of novel cancer technologies and find ways to better deliver cancer services Toronto (June 4, 2019) – The Ontario Institute for Cancer Research (OICR) today announced funding for 10 projects as part of the OICR-Cancer Care Ontario (CCO) Health Services Research Network (HSRN). (more…)

Data Hackathon on Health Equity – Sign Up Today!

/0 Comments/in , /by
Check our this amazing opportunity sponsored by the Canadian Partnership Against Cancer. Health services researchers and analysts from across Canada are invited to participate in a data hackathon taking place on November 2, 2019 in Ottawa, Ontario. The hackathon, Unleashing the power of linked cancer data, will help expand knowledge of health (more…)

CIHR/CCS: Cancer Survivorship Team Grants

/0 Comments/in , /by
Registration Deadline: May 29,  2019 Full Application Deadline: September 10, 2019 Anticipated Funding Start Date:  December 1, 2019 The Canadian Institutes of Health Research (CIHR) – Institutes of Cancer Research (ICR) and the Canadian Cancer Society are pleased to announce the following funding opportunity: Cancer Survivorship Team Grants The goal of the CCS/CIHR Cancer Survivorship (more…)

CCS: Excess weight expected to become 2nd leading preventable cause of cancer, after tobacco

/0 Comments/in /by
The below post is a copy of the news release published by the Canadian Cancer Society at https://bit.ly/2E83hbF A Canadian Cancer Society (CCS)-funded study has found that, unless Canada makes changes, excess weight will become the second leading preventable cause of cancer, following tobacco. The Canadian Population Attributable Risk of Cancer (more…)

OICR-ARCC Sponsored Costing Supplement in Current Oncology – Now Available!

/0 Comments/in /by
Special supplement on Canadian cancer costing research ARCC is pleased to have partnered with the Ontario Institute for Cancer Research on a special supplement of Canadian cancer costing research, published today in Current Oncology. From ARCC’s Commentary: “As we approach the 10th anniversary of the Canadian Centre for Applied Research in (more…)

Dalhousie Medical Research Foundation Conference Grant Awarded

/0 Comments/in /by
The Canadian Centre for Applied Research in Cancer Control (ARCC) is proud to announce that the Dalhousie Medical Research Foundation (DMRF) has awarded a Conference Grant in support of the 2019 ARCC Conference, being held May 27-28, 2019, at the Halifax Convention Centre. The DMRF grant application was co-supported by Dalhousie (more…)

2019 Spring and Summer R Course Series (Toronto, ON)

/0 Comments/in , /by
The Biostatistics Research Unit (BRU) in partnership with the Toronto Health Economics and Technology Assessment (THETA) Collaborative will be hosting a series of short courses on R. R is a powerful and flexible software environment for statistical analysis and graphics. R is freely available, facilitating analysis and model transparency and reproducibility. (more…)

Join Canada’s cancer research community at the 2019 Canadian Cancer Research Conference!

/0 Comments/in , /by
Mark your calendars for the Canadian Cancer Research Conference taking place November 3 to 5, 2019 in Ottawa, Ontario. Hosted by the Canadian Cancer Research Alliance, this three-day event brings together researchers, clinicians, decision-makers, and trainees at all stages of their career. Abstract Submission for the 2019 CCRC will open (more…)

University of Manitoba – Canada Research Chair Tier 2, Health Economics

/0 Comments/in , /by
CANADA RESEARCH CHAIR TIER 2, HEALTH ECONOMICS POSTED: March 11, 2019, Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences Position Numbers 27187 and 27816. The University of Manitoba invites applications for a Tier 2 Canada Research Chair, a tenured or tenure-track position at (more…)

BioCanRx – Research Program Renewal, Call for LOI’s

/0 Comments/in , /by
Bench to Bedside Translation of Innovative Cancer Biotherapeutics BioCanRx, Canada’s Immunotherapy Network, is pleased to announce its 2019 Call for Letters of Intent. Selected Letters of Intent will be featured in the Scientific Program of our Cycle II application going forward for review in July 2019 to the federal government’s (more…)